Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Shares Issued (2016 - 2025)

Pediatrix Medical (MD) has disclosed Shares Issued for 17 consecutive years, with $646000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 11.75% to $646000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 12.48% decrease, with the full-year FY2025 number at $3.2 million, down 12.48% from a year prior.
  • Shares Issued was $646000.0 for Q4 2025 at Pediatrix Medical, down from $700000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $3.0 million in Q3 2021 to a low of $646000.0 in Q4 2025.
  • A 5-year average of $1.2 million and a median of $1.2 million in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 129.6% in 2021, then plummeted 54.43% in 2022.
  • Pediatrix Medical's Shares Issued stood at $1.2 million in 2021, then decreased by 5.31% to $1.2 million in 2022, then fell by 11.9% to $1.0 million in 2023, then decreased by 29.34% to $732000.0 in 2024, then fell by 11.75% to $646000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Shares Issued are $646000.0 (Q4 2025), $700000.0 (Q3 2025), and $1.2 million (Q2 2025).